Thrombin Time (T.T.)

Thrombin Time is a blood coagulation test that measures how long it takes for a clot to form after thrombin is added directly to a plasma sample. It evaluates the final step of the coagulation cascade – the conversion of fibrinogen into fibrin – which is essential for the formation of a stable blood clot. Unlike PT and aPTT, which assess broader coagulation pathways, Thrombin Time specifically isolates this last conversion step, making it a targeted and precise diagnostic tool for clotting abnormalities.

Why Consider This Test?

●     Unexplained Bleeding: Helps investigate prolonged or unexplained bleeding episodes that are not explained by routine coagulation tests.

●     Fibrinogen Abnormalities: Detects conditions such as hypofibrinogenemia (low fibrinogen), afibrinogenemia (absent fibrinogen), or dysfibrinogenemia (dysfunctional fibrinogen), all of which impair normal clot formation.

●     Heparin Monitoring: Highly sensitive to the presence of heparin in the blood, making it useful in monitoring patients on heparin therapy or detecting residual heparin after procedures.

●     Direct Thrombin Inhibitors: Helps monitor the effect of direct thrombin inhibitor medications such as argatroban or dabigatran.

●     Abnormal PT/aPTT Results: Ordered as a follow-up when other coagulation tests return abnormal results and further investigation into the fibrin formation step is needed.

●     Fibrin Degradation Products: Identifies interference caused by elevated fibrin degradation products (FDPs), which can occur in conditions like DIC (Disseminated Intravascular Coagulation).

Who Should Get This Test Done?

This test is recommended for:

●     Individuals experiencing unexplained or recurrent bleeding episodes

●     Individuals diagnosed with or suspected of having a hereditary or acquired fibrinogen disorder

●     Those undergoing heparin therapy or treatment with direct thrombin inhibitors

●     Individuals with suspected DIC or other systemic clotting disorders

●     Individuals with abnormal PT or aPTT results requiring further coagulation workup

●     Pre-surgical patients with a known or suspected bleeding tendency

More Information

Thrombin Time (TT) directly evaluates the final step of coagulation by measuring the conversion of fibrinogen to fibrin after adding thrombin, bypassing the earlier stages of the clotting cascade.

●     A prolonged TT suggests low fibrinogen levels, abnormal fibrinogen, or the presence of inhibitors such as heparin, fibrin degradation products (FDPs), or paraproteins.

●     It is commonly performed alongside PT, aPTT, and fibrinogen assays to identify the specific site of a clotting defect.

●     TT is particularly useful in emergency and critical care settings, evaluation of suspected Disseminated Intravascular Coagulation (DIC), and pre-surgical bleeding risk assessment.

Other names:

●     Thrombin Clotting Time (TCT)

●     TT Test

●      Plasma Thrombin Time